Cite
Improvement in social functioning in outpatients with schizophrenia with prominent negative symptoms treated with olanzapine or risperidone in a 1 year randomized, open-label trial.
MLA
Ciudad, Antonio, et al. “Improvement in Social Functioning in Outpatients with Schizophrenia with Prominent Negative Symptoms Treated with Olanzapine or Risperidone in a 1 Year Randomized, Open-Label Trial.” Progress in Neuro-Psychopharmacology & Biological Psychiatry, vol. 30, no. 8, Dec. 2006, pp. 1515–22. EBSCOhost, https://doi.org/10.1016/j.pnpbp.2006.05.010.
APA
Ciudad, A., Olivares, J. M., Bousoño, M., Gómez, J. C., & Alvarez, E. (2006). Improvement in social functioning in outpatients with schizophrenia with prominent negative symptoms treated with olanzapine or risperidone in a 1 year randomized, open-label trial. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 30(8), 1515–1522. https://doi.org/10.1016/j.pnpbp.2006.05.010
Chicago
Ciudad, Antonio, José M Olivares, Manuel Bousoño, Juan C Gómez, and Enrique Alvarez. 2006. “Improvement in Social Functioning in Outpatients with Schizophrenia with Prominent Negative Symptoms Treated with Olanzapine or Risperidone in a 1 Year Randomized, Open-Label Trial.” Progress in Neuro-Psychopharmacology & Biological Psychiatry 30 (8): 1515–22. doi:10.1016/j.pnpbp.2006.05.010.